Bruker BRKR R&D
R&D at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Bruker in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.
The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bruker's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bruker's R&D?
- Bruker (BRKR) reported R&D of $101.3M in Q1 2026.
- How has Bruker's R&D changed year-over-year?
- Bruker's R&D increased by 4.3% year-over-year, from $97.1M to $101.3M.
- What is the long-term trend for Bruker's R&D?
- Over 4 years (2021 to 2025), Bruker's R&D has grown at a 15.7% compound annual growth rate (CAGR), from $220.8M to $395.2M.
- What does R&D mean?
- The money spent on creating new products or improving existing ones.
- How do you interpret R&D?
- Higher spending indicates a commitment to innovation and future growth, while a significant decline may signal a reduction in long-term competitive positioning.
- How does R&D compare across companies?
- High R&D intensity is typical for technology and life science companies compared to mature industrial firms.